After a landmark 2025 result slowing Huntington's disease, follow-on data and regulatory steps are expected. Resolves YES if a Huntington's disease therapy reports a positive pivotal readout or regulatory filing in 2026. Source: Nature / company releases.
Market open
Jun 15, 2026, 03:26 p.m.
Market closes
Jan 8, 2027, 02:26 p.m.
Projected payout
After market closes
